The use of lipid-based nanocarriers for targeted pain therapies

por Hua, Susan, Wu, Sherry Y.
Publicado 2013

The Advances and Challenges in Utilizing Exosomes for Delivering Cancer Therapeutics

por Yang, Mengliu, Wu, Sherry Y.
Publicado 2018

Editorial: Advances and Challenges in Nanomedicine

por Hua, Susan, Wu, Sherry Y.
Publicado 2018

Effective Delivery of PEGylated siRNA-Containing Lipoplexes to Extraperitoneal Tumours following Intraperitoneal Administration

por Singhania, Akul, Wu, Sherry Y., McMillan, Nigel A. J.
Publicado 2011

Advances and Challenges of Liposome Assisted Drug Delivery

por Sercombe, Lisa, Veerati, Tejaswi, Moheimani, Fatemeh, Wu, Sherry Y., Sood, Anil K., Hua, Susan
Publicado 2015

Immune cell profiling in cancer: molecular approaches to cell-specific identification

por Lyons, Yasmin A., Wu, Sherry Y., Overwijk, Willem W., Baggerly, Keith A., Sood, Anil K.
Publicado 2017

HIF and COX-2 expression in triple negative breast cancer cells with hypoxia and 5-fluorouracil

por Mori, Noriko, Mironchik, Yelena, Wildes, Flonné, Wu, Sherry Y., Mori, Kanami, Krishnamachary, Balaji, Bhujwalla, Zaver M.
Publicado 2020

Pan-cancer genomic analysis links 3’UTR DNA methylation with increased gene expression in T cells

por McGuire, Michael H., Herbrich, Shelley M., Dasari, Santosh K., Wu, Sherry Y., Wang, Ying, Rupaimoole, Rajesha, Lopez-Berestein, Gabriel, Baggerly, Keith A., Sood, Anil K.
Publicado 2019

ADH1B promotes mesothelial clearance and ovarian cancer infiltration

por Gharpure, Kshipra M., Lara, Olivia D., Wen, Yunfei, Pradeep, Sunila, LaFargue, Chris, Ivan, Cristina, Rupaimoole, Rajesha, Hu, Wei, Mangala, Lingegowda S., Wu, Sherry Y., Nagaraja, Archana S., Baggerly, Keith, Sood, Anil K.
Publicado 2018

Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy

por Gaur, Sanchaika, Wen, Yunfei, Song, Jian H., Parikh, Nila U., Mangala, Lingegowda S., Blessing, Alicia M., Ivan, Cristina, Wu, Sherry Y., Varkaris, Andreas, Shi, Yan, Lopez-Berestein, Gabriel, Frigo, Daniel E., Sood, Anil K., Gallick, Gary E.
Publicado 2015

miR-146a inhibits ovarian tumor growth in vivo via targeting immunosuppressive neutrophils and enhancing CD8(+) T cell infiltration

por Chen, Rui, Coleborn, Elaina, Bhavsar, Chintan, Wang, Yue, Alim, Louisa, Wilkinson, Andrew N., Tran, Michelle A., Irgam, Gowri, Atluri, Sharat, Wong, Kiefer, Shim, Jae-Jun, Adityan, Siddharth, Lee, Ju-Seog, Overwijk, Willem W., Steptoe, Raymond, Yang, Da, Wu, Sherry Y.
Publicado 2023

Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype

por Ma, Shaolin, McGuire, Michael H., Mangala, Lingegowda S., Lee, Sanghoon, Stur, Elaine, Hu, Wen, Bayraktar, Emine, Villar-Prados, Alejandro, Ivan, Cristina, Wu, Sherry Y., Yokoi, Akira, Dasari, Santosh K., Jennings, Nicholas B., Liu, Jinsong, Lopez-Berestein, Gabriel, Ram, Prahlad, Sood, Anil K.
Publicado 2021

Molecular Analysis of Short- versus Long-Term Survivors of High-Grade Serous Ovarian Carcinoma

por Stur, Elaine, Bayraktar, Emine, Dal Molin, Graziela Zibetti, Wu, Sherry Y., Mangala, Lingegowda S., Yao, Hui, Wang, Ying, Ram, Prahlad T., Corvigno, Sara, Chen, Hu, Liang, Han, Tworoger, Shelley S., Levine, Douglas A., Lutgendorf, Susan K., Liu, Jinsong, Moore, Kathleen N., Baggerly, Keith A., Karlan, Beth Y., Sood, Anil K.
Publicado 2022

Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression

por Rupaimoole, Rajesha, Ivan, Cristina, Yang, Da, Gharpure, Kshipra M., Wu, Sherry Y., Pecot, Chad V., Previs, Rebecca A., Nagaraja, Archana S., Armaiz-Pena, Guillermo N, McGuire, Michael, Pradeep, Sunila, Mangala, Lingegowda S., Rodriguez-Aguayo, Cristian, Huang, Li, Bar-Eli, Menashe, Zhang, Wei, Lopez-Berestein, Gabriel, Calin, George A., Sood, Anil K.
Publicado 2016

PRKCI promotes immune suppression in ovarian cancer

por Sarkar, Sharmistha, Bristow, Christopher A., Dey, Prasenjit, Rai, Kunal, Perets, Ruth, Ramirez-Cardenas, Alejandra, Malasi, Shruti, Huang-Hobbs, Emmet, Haemmerle, Monika, Wu, Sherry Y., McGuire, Michael, Protopopov, Alexei, Jiang, Shan, Liu, Joyce F., Hirsch, Michelle S., Chang, Qing, Lazar, Alexander J., Sood, Anil K., Drapkin, Ronny, DePinho, Ronald, Draetta, Giulio, Chin, Lynda
Publicado 2017

Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis

por Nagaraja, Archana S., Dorniak, Piotr L., Sadaoui, Nouara C., Kang, Yu, Lin, Tan, Armaiz-Pena, Guillermo, Wu, Sherry Y., Rupaimoole, Rajesha, Allen, Julie K., Gharpure, Kshipra M., Pradeep, Sunila, Zand, Behrouz, Previs, Rebecca A., Hansen, Jean M., Ivan, Cristina, Rodriguez-Aguayo, Cristian, Yang, Peiying, Lopez-Berestein, Gabriel, Lutgendorf, Susan K., Cole, Steve W., Sood, Anil K.
Publicado 2015

Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy

por Lyons, Yasmin A., Pradeep, Sunila, Wu, Sherry Y., Haemmerle, Monika, Hansen, Jean M., Wagner, Michael J., Villar-Prados, Alejandro, Nagaraja, Archana S., Dood, Robert L., Previs, Rebecca A., Hu, Wei, Zhao, Yang, Mak, Duncan H., Xiao, Zhilan, Melendez, Brenda D., Lizee, Gregory A., Mercado-Uribe, Imelda, Baggerly, Keith A., Hwu, Patrick, Liu, Jinsong, Overwijk, Willem W., Coleman, Robert L., Sood, Anil K.
Publicado 2017

Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens

por Nagaraja, Archana S., Dood, Robert L., Armaiz-Pena, Guillermo, Kang, Yu, Wu, Sherry Y., Allen, Julie K., Jennings, Nicholas B., Mangala, Lingegowda S., Pradeep, Sunila, Lyons, Yasmin, Haemmerle, Monika, Gharpure, Kshipra M., Sadaoui, Nouara C., Rodriguez-Aguayo, Cristian, Ivan, Cristina, Wang, Ying, Baggerly, Keith, Ram, Prahlad, Lopez-Berestein, Gabriel, Liu, Jinsong, Mok, Samuel C., Cohen, Lorenzo, Lutgendorf, Susan K., Cole, Steve W., Sood, Anil K.
Publicado 2021

CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance

por Ma, Shaolin, Mangala, Lingegowda S., Hu, Wen, Bayaktar, Emine, Yokoi, Akira, Hu, Wei, Pradeep, Sunila, Lee, Sanghoon, Piehowski, Paul D., Villar-Prados, Alejandro, Wu, Sherry Y., McGuire, Michael H., Lara, Olivia D., Rodriguez-Aguayo, Cristian, LaFargue, Christopher J., Jennings, Nicholas B., Rodland, Karin D., Liu, Tao, Kundra, Vikas, Ram, Prahlad T., Ramakrishnan, Sundaram, Lopez-Berestein, Gabriel, Coleman, Robert L., Sood, Anil K.
Publicado 2021

FABP4 as a key determinant of metastatic potential of ovarian cancer

por Gharpure, Kshipra M., Pradeep, Sunila, Sans, Marta, Rupaimoole, Rajesha, Ivan, Cristina, Wu, Sherry Y., Bayraktar, Emine, Nagaraja, Archana S., Mangala, Lingegowda S., Zhang, Xinna, Haemmerle, Monika, Hu, Wei, Rodriguez-Aguayo, Cristian, McGuire, Michael, Mak, Celia Sze Ling, Chen, Xiuhui, Tran, Michelle A., Villar-Prados, Alejandro, Pena, Guillermo Armaiz, Kondetimmanahalli, Ragini, Nini, Ryan, Koppula, Pranavi, Ram, Prahlad, Liu, Jinsong, Lopez-Berestein, Gabriel, Baggerly, Keith, S. Eberlin, Livia, Sood, Anil K.
Publicado 2018